Search results for "Vaccinations"
Infusion sets, heparin recalled
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/10/infusion-sets-heparin-recalled.htm
1 Oct 2020
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
The push toward a COVID-19 vaccine
As America closes in on a vaccine for COVID-19, experts focus on which ones will work best, if at all, how to ramp up production, and how to fairly administer millions of doses.
https://immattersacp.org/archives/2020/11/the-push-toward-a-covid-19-vaccine.htm
1 Nov 2020
COVID-19 Vaccine Forum II—Promoting COVID-19 Vaccination: What Physicians Need to Know
The virtual live event hosted by ACP and Annals of Internal Medicine on Dec. 16 will provide unique insight and practical information from a panel of experts on promoting COVID-19 vaccination confidence and uptake.
https://immattersacp.org/weekly/archives/2020/12/08/2.htm
8 Dec 2020
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020
Still time to register for COVID-19 Vaccine Forum II—Promoting COVID-19 Vaccination: What Physicians Need to Know
The virtual live event hosted by ACP and Annals of Internal Medicine on Wednesday, Dec. 16, will provide unique insight and practical information from a panel of experts on promoting COVID-19 vaccination confidence and uptake.
https://immattersacp.org/weekly/archives/2020/12/15/2.htm
15 Dec 2020
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
https://immattersacp.org/weekly/archives/2020/12/15/5.htm
15 Dec 2020
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
New authorization, guidance on vaccines against SARS-CoV-2
The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020
Getting patients to ‘yes' on COVID-19 vaccines
Experts believe practicing physicians are well positioned to take a lead role combating one of the biggest anticipated obstacles to widespread vaccination: vaccine hesitancy.
https://immattersacp.org/archives/2021/01/getting-patients-to-yes-on-covid-19-vaccines.htm
1 Jan 2021